The U.S. Food and Drug Administration (FDA) issued a complete response letter requesting additional information from AstraZeneca regarding the Biologics License Application (BLA) for subcutaneous (SC) ...
Congress has taken the final steps in the FY 2026 budget process, passing legislation that increases funding for lupus programs, including $27 million - the most in history - for lupus programs at the ...
Learn more about how your company or organization can raise its profile and morale by becoming a corporate partner.
Black History Month serves as a reminder to actively amplify Black voices, share stories and raise awareness throughout the year. This month, we’re featuring Danielle Storr, a Black lupus warrior who ...
In this episode of the Lupus Foundation of America's The Expert Series podcast, we focus on the newly released American College of Rheumatology treatment guidelines for systemic lupus erythematosus ...
The U.S. Food and Drug Administration (FDA) has granted Biogen’s investigational drug, litifilimab, Breakthrough Therapy Designation for the treatment of cutaneous lupus erythematosus (CLE).
Our approach is innovative and removes barriers to progress. Watch this short video about three of our bold research initiatives to better understand lupus in children and teens, improve early ...
Interested in getting research like this straight to your inbox? Subscribe to our monthly Inside Lupus Research email for all the latest. Discover and match to lupus clinical trials faster with our ...
Our most recent episode of The Expert Series podcast explores the newly released SLE treatment guidelines and how they might affect patient care.
Most people with lupus have antinuclear antibodies (ANAs) in their blood. But a positive ANA test doesn’t always mean lupus. The test can be positive in people with other autoimmune illnesses — ...
Anyone can get lupus, no matter their age or sex. But it’s less common for men to get lupus, with about 1 in every 10 cases happening in men. Experts still aren’t sure exactly why. Learn more about ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results